Company: IMNN
Filing Date: 2025-04-04
Form Type: S-1
Source: 0001641172-25-002783
Chunk: 7

Company: Imunon, Inc.
Filing Date: 2025-04-04
Form: S-1
Chunk 7
---
 Arcadia Securities, LLC

The date of this prospectus is , 2025.</div>

<div align='center'>TABLE OF CONTENTS</div>

| CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS   |  1 |
| ABOUT THIS PROSPECTUS                                    |  2 |
| PROSPECTUS SUMMARY                                       |  3 |
| THE OFFERING                                             |  4 |
| RISK FACTORS                                             |  6 |
| CAPITALIZATION                                           | 10 |
| DILUTION                                                 | 11 |
| USE OF PROCEEDS                                          | 12 |
| DESCRIPTION OF CAPITAL STOCK                             | 13 |
| DESCRIPTION OF SECURITIES WE ARE OFFERING                | 18 |
| PLAN OF DISTRIBUTION                                     | 21 |
| MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS | 24 |
| DIVIDEND POLICY                                          | 28 |
| LEGAL MATTERS                                            | 29 |
| EXPERTS                                                  | 29 |
| WHERE YOU CAN FIND MORE INFORMATION                      | 29 |
| INCORPORATION OF CERTAIN INFORMATION BY REFERENCE        | 30 |

| i |

<div align='center'>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</div>

Certain statements contained or incorporated by reference in this prospectus and in any related free writing prospectus may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and releases issued by the SEC and within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”). Forward-looking statements may relate to such matters as anticipated financial performance, business prospects, technological developments, product pipelines, clinical trials and research and development activities, the adequacy of capital reserves and anticipated operating results and cash expenditures, current and potential collaborations, strategic alternatives and other aspects of our present and future business operations and similar matters. These statements involve known and unknown risks, uncertainties and other factors, many of which are outside of our control, that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Such statements include, without limitation:

| ● | any                                                                                                                                     
 statements regarding future operations, plans, regulatory filings or approvals, including the plans and objectives of management        
 for future operations or programs or proposed